227
Views
0
CrossRef citations to date
0
Altmetric
Computational Life Sciences, Bioinformatics and System Biology

The predictive value of admission serum and urine carboxypeptidase-B activation peptide for the severity of acute pancreatitis: a meta-analysis

, , , , , , , & show all
Article: 2288534 | Received 14 Dec 2022, Accepted 01 Oct 2023, Published online: 01 Dec 2023

References

  • Abu Hilal M, Ung CT, Westlake S, et al. 2007 Mar. Carboxypeptidase-B activation peptide, a marker of pancreatic acinar injury, but not L-selectin, a marker of neutrophil activation, predicts severity of acute pancreatitis. J Gastroenterol Hepatol. 22(3):349–354. doi:10.1111/j.1440-1746.2006.04550.x.
  • Appelros S, Petersson U, Toh S, et al. 2001 Feb. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br J Surg. 88(2):216–221.
  • Appelros S, Thim L, Borgström A. 1998 Jan. Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis. Gut. 42(1):97–102. doi:10.1136/gut.42.1.97.
  • Banks PA, Bollen TL, Dervenis C, et al. 2013 Jan. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 62(1):102–111. doi:10.1136/gutjnl-2012-302779.
  • Deeks JJ, Macaskill P, Irwig L. 2005 Sep. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 58(9):882–893. doi:10.1016/j.jclinepi.2005.01.016.
  • Deng L, Wang L, Yong F, et al. 2015 Jul. Prediction of the severity of acute pancreatitis on admission by carboxypeptidase-B activation peptide: a systematic review and meta-analysis. Clin Biochem. 48(10–11):740–746. doi:10.1016/j.clinbio-chem.2015.06.003.
  • DerSimonian R, Laird N. 1986 Sep. Meta-analysis in clinical trials. Control Clin Trials. 7(3):177–188. doi:10.1016/0197-2456(86)90046-2.
  • Hjalmarsson C, Stenflo J, Borgström A. 2009. Activated protein C-protein C inhibitor complex, activation peptide of carboxypeptidase B and C-reactive protein as predictors of severe acute pancreatitis. Pancreatology: Official Journal of the International Association of Pancreatology (IAP) [et al]. 9(5):700–707. doi:10.1159/000215577.
  • Huh JH, Jeon H, Park SM, et al. 2018 Feb. Diabetes mellitus is associated with mortality in acute pancreatitis. J Clin Gastroenterol. 52(2):178–183. doi:10.1097/MCG.0000000000-000783.
  • Huh JH, Jung S, Cho SK, et al. 2018 Feb. Predictive value of apolipoprotein B and A-I ratio in severe acute pancreatitis. J Gastroenterol Hepatol. 33(2):548–553. doi:10.1111/jgh.13860.
  • Larvin M, McMahon MJ. 1989 Jul 22. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet (London, England). 2(8656):201–205.
  • Moher D, Liberati A, Tetzlaff J, et al. 2009 Jul 21. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6(7):e1000097. doi:10.1371/journal.pmed.1000100.
  • Mounzer R, Langmead CJ, Wu BU, et al. 2012 Jun. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology. 142(7):1476–1482; quiz e15–6. doi:10.1053/j.gastro.2012.04.034.
  • Müller CA, Appelros S, Uhl W, et al. 2002 Aug. Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut. 51(2):229–235. doi:10.1136/gut.51.2.229.
  • Peery AF, Crockett SD, Barritt AS, et al. 2015 Dec. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 149(7):1731–1741.e3. doi:10.1053/j.gastro.2015.08.045.
  • Pezzilli R, Morselli-Labate AM, Barbieri AR, et al. 2000 Sep. Clinical usefulness of the serum carboxypeptidase B activation peptide in acute pancreatitis. JOP: Journal of the Pancreas. 1(3):58–68.
  • Ranson JH, Rifkind KM, Roses DF, et al. 1974 Jun. Objective early identification of severe acute pancreatitis. Am J Gastroenterol. 61(6):443–451.
  • Regnér S, Appelros S, Hjalmarsson C, et al. 2008. Monocyte chemoattractant protein 1, active carboxypeptidase B and CAPAP at hospital admission are predictive markers for severe acute pancreatitis. Pancreatology: Official Journal of the International Association of Pancreatology (IAP) [et al]. 8(1):42–49. doi:10.1159/000114866.
  • Roberts SE, Morrison-Rees S, John A, et al. 2017 Mar-Apr. The incidence and aetiology of acute pancreatitis across Europe. Pancreatology: Official Journal of the International Association of Pancreatology (IAP) [et al]. 17(2):155–165.
  • Sáez J, Martínez J, Trigo C, et al. 2004 Jul. A comparative study of the activation peptide of carboxypeptidase B and trypsinogen as early predictors of the severity of acute pancreatitis. Pancreas. 29(1):e9–14.
  • van Dijk SM, Hallensleben NDL, van Santvoort HC, et al. 2017 Nov. Acute pancreatitis: recent advances through randomised trials. Gut. 66(11):2024–2032. doi:10.1136/gutjnl-2016-313595.
  • Walter SD. 2002 May 15. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med. 21(9):1237–1256. doi:10.1002/sim.1099.
  • Whiting PF, Rutjes AW, Westwood ME, et al. 2011 Oct 18. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 155(8):529–536. doi:10.7326/0003-4819-155-8-201110180-00009.
  • Woodward M. 2013. Epidemiology: study design and data analysis. 3rd Edition. Chapman & Hall/CRC Texts in Statistical Science Ser. Chapman & Hall/CRC.
  • Wu BU, Johannes RS, Sun X, et al. 2008 Dec. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 57(12):1698–1703. doi:10.1136/gut.2008.152702.